Rizatriptan manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

rizatriptan

Tablets 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
South Africa , United Kingdom
Registered in
United States
Manufacturer #638

A pharmaceutical manufacturer producing a broad range of pharmaceutical products that include finished dosage forms such as tablets, capsules, oral liquids and other formulations for various therapeutic areas, as well as active pharmaceutical ingredients used in drug manufacture and export to global markets. The company integrates research and development with large-scale production and maintains quality systems aligned with industry standards to support safety, consistency and compliance in the development and supply of its pharmaceutical products.

Differentiated dosage form - Oral Disintegrating Strip

rizatriptan

Oral film 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #36950
European pharmaceutical company with experience in developing and commercializing specialty and generic Rx medicines for European and international markets. Oral solid, liquid, and injectable dosage forms cover key therapeutic areas. Engages in strategic licensing partnerships for product development and market expansion.

rizatriptan

Tablets, orally disintegrating (ODT) 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Reference product: Maxalt®. DCP status: Completed
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.